These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15904556)

  • 1. Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.
    Hippisley-Cox J; Pringle M; Cater R; Coupland C; Meal A
    Br J Gen Pract; 2005 May; 55(514):369-75. PubMed ID: 15904556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid lowering in patients with diabetes mellitus: what coronary heart disease risk threshold should be used?
    Rowland Yeo K; Yeo WW
    Heart; 2002 May; 87(5):423-7. PubMed ID: 11997409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey.
    Hippisley-Cox J; Pringle M; Crown N; Meal A; Wynn A
    BMJ; 2001 Apr; 322(7290):832. PubMed ID: 11290638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
    Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current targets: where are we today?
    Pringle M
    Heart; 2003 May; 89 Suppl 2(Suppl 2):ii10-2; discussion ii35-7. PubMed ID: 12695427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.
    Gemmell I; Heller RF; Payne K; Edwards R; Roland M; Durrington P
    Qual Saf Health Care; 2006 Oct; 15(5):339-43. PubMed ID: 17074870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register.
    Carroll K; Majeed A; Firth C; Gray J
    J Public Health Med; 2003 Mar; 25(1):29-35. PubMed ID: 12669915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey.
    Haq IU; Ramsay LE; Wallis EJ; Isles CG; Ritchie LD; Jackson PR
    Heart; 2001 Sep; 86(3):289-95. PubMed ID: 11514481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid lowering and coronary heart disease risk: how appropriate are the national guidelines?
    Forge BH; Briganti EM
    Med J Aust; 2001 Nov; 175(9):471-5. PubMed ID: 11758075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000.
    Vale MJ; Jelinek MV; Best JD;
    Med J Aust; 2002 Mar; 176(5):211-5. PubMed ID: 11999236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering for prevention of coronary heart disease: what policy now?
    Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN
    Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial.
    Feder G; Griffiths C; Eldridge S; Spence M
    BMJ; 1999 Jun; 318(7197):1522-6. PubMed ID: 10356008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid lowering therapy for primary prevention of coronary heart disease--pro lipid lowering therapy].
    Steinmetz A; Noll B; Maisch B; Schäfer JR
    Z Kardiol; 1998; 87 Suppl 2():205-9. PubMed ID: 9827484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention of coronary heart disease in older British men: extent of inequalities before and after implementation of the National Service Framework.
    Ramsay SE; Morris RW; Papacosta O; Lennon LT; Thomas MC; Whincup PH
    J Public Health (Oxf); 2005 Dec; 27(4):338-43. PubMed ID: 16162637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductions in risk factors for secondary prevention of coronary heart disease by ethnic group in south-west London: 10-year longitudinal study (1998-2007).
    Murray J; Saxena S; Millett C; Curcin V; de Lusignan S; Majeed A
    Fam Pract; 2010 Aug; 27(4):430-8. PubMed ID: 20538744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
    Ansell BJ; Watson KE; Fogelman AM
    JAMA; 1999 Dec; 282(21):2051-7. PubMed ID: 10591388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
    Pedersen E; Garcia BH; Halvorsen KH; Eggen AE; Schirmer H; Waaseth M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):44. PubMed ID: 33478404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
    Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
    BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.